Achilles Therapeutics Plc ADR (NASDAQ: ACHL): Can A Stock Be Up 40.61% YTD, And Still Be A Loser
Achilles Therapeutics Plc ADR (NASDAQ:ACHL)’s traded shares stood at 0.28 million during the last session, with the company’s beta value hitting 1.08. At the close